Corey Lactone Diol

CAS No. 32233-40-2

Corey Lactone Diol( (-)-Corey lactone diol )

Catalog No. M21346 CAS No. 32233-40-2

Corey Lactone Diol is a pharmaceutical intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Corey Lactone Diol
  • Note
    Research use only, not for human use.
  • Brief Description
    Corey Lactone Diol is a pharmaceutical intermediate.
  • Description
    Corey Lactone Diol is a pharmaceutical intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Corey lactone diol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32233-40-2
  • Formula Weight
    172.18
  • Molecular Formula
    C8H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:34 mg/mL (197.46 mM)
  • SMILES
    OC[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Achmatowicz B Baranowska E Daniewski A R et al. A novel approach to prostaglandins from the corey lactone involving BF3-mediated reactions of a sulphone and aldehydes[J]. Tetrahedron Letters 1985 26(45):5597–5600.
molnova catalog
related products
  • neo-gambogic acid

    Neogambogic acid an active ingredient in garcinia can inhibit the growth of some solid tumors and result in an anticancer effect it may be responsible for the inhibition of proliferation of human breast cancer cell line MCF-7 cells.

  • Verdiperstat

    Verdiperstat (AZD-3241) is a potent, selective, reversible, orally active myeloperoxidase (MPO) inhibitor with IC50 of 630 nM, >14-fold selectivity over thyroid peroxidase (TPO).

  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.